In Vitro Diagnostics (IVD): Laboratory Testing and Centralized vs. Distributed
In vitro diagnostics market reached $68.2B in 2024 with clinical chemistry and immunoassay representing 48% of testing volume. Centralized laboratory testing maintained dominance with 76% of clinical testing volume. Point-of-care and decentralized testing captured growth at 18% CAGR driven by COVID-era innovations and workflow improvements.
Drivers, Challenges & Trends
Key Market Drivers
Market growth expected at strong CAGR through the forecast period, driven by rising demand, technology adoption, and expanding end-user applications globally.
Growth Challenges
Complex regulatory landscapes, high R&D costs, supply chain constraints, and competitive intensity present challenges for market participants.
Emerging Trends
Digital transformation, AI integration, sustainability initiatives, and evolving consumer preferences are reshaping industry dynamics and creating new opportunities.
Strategic Opportunities
Regional expansion, product innovation, strategic partnerships, and technology-enabled solutions offer significant growth potential for forward-looking companies.
What's Inside the Report
- Executive Summary
- IVD Market Overview
- Testing Modalities
- Centralized vs. Decentralized
- Consolidation Trends
- Reimbursement
- Automation Impact
- Future Outlook
- Appendix
Sample Report Content
Get a glimpse of the comprehensive analysis included in this report.
Market Overview
In vitro diagnostics market reached $68.2B in 2024 with clinical chemistry and immunoassay representing 48% of testing volume. Centralized laboratory testing maintained dominance with 76% of clinical testing volume. Point-of-care and decentralized testing captured growth at 18% CAGR driven by COVID-era innovations and workflow improvements.
Market Segmentation Breakdown
By Type
By Application
By Distribution Channel
By Region
Our Research Approach
IVD company tracking, 220 clinical lab director interviews, testing volume analysis, consolidation assessment
Data Sources
Companies Profiled
Strategic profiles of key players with SWOT analysis, financials, product portfolios, and recent developments included in this report.